chelerythrine has been researched along with 7-benzylidenenaltrexone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gross, GJ; Huh, J; Liang, BT; Nagase, H | 1 |
Fryer, RM; Gross, GJ; Hsu, AK; Wang, Y | 1 |
Barzakh, EI; Chernysheva, GA; Cybulnikov, SY; Krieg, T; Krylatov, AV; Lishmanov, AY; Maslov, LN; Solenkova, NV; Zhang, Y | 1 |
3 other study(ies) available for chelerythrine and 7-benzylidenenaltrexone
Article | Year |
---|---|
Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels.
Topics: Adenosine Triphosphate; Alkaloids; Animals; Benzophenanthridines; Benzylidene Compounds; Cells, Cultured; Chick Embryo; Enzyme Inhibitors; Glyburide; Heart; Ischemia; Ischemic Preconditioning, Myocardial; Mitochondria, Heart; Myocardium; Naltrexone; Narcotic Antagonists; Phenanthridines; Potassium Channel Blockers; Protein Kinase C; Quinolines | 2001 |
Essential activation of PKC-delta in opioid-initiated cardioprotection.
Topics: Acetophenones; Alkaloids; Analgesics; Animals; Benzophenanthridines; Benzopyrans; Benzylidene Compounds; Enkephalin, Leucine-2-Alanine; Enzyme Activation; Enzyme Inhibitors; Heart Rate; Indoles; Ischemic Preconditioning, Myocardial; Isoenzymes; Male; Maleimides; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Naltrexone; Narcotic Antagonists; Phenanthridines; Protein Kinase C; Protein Kinase C-delta; Quinolines; Rats; Rats, Wistar; Receptors, Opioid, delta | 2001 |
Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of δ₂-opioid receptors, protein kinase C, and K(ATP) channels.
Topics: Animals; Benzophenanthridines; Benzylidene Compounds; Decanoic Acids; Glyburide; Hydroxy Acids; Ischemic Preconditioning, Myocardial; Male; Myocardial Reperfusion Injury; Naltrexone; Oligopeptides; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rats; Rats, Wistar; Receptors, Opioid, delta | 2010 |